Inflammopharmacology logo VSP, an imprint of Brill logo

Publisher: VSP, an imprint of Brill

Volume 10, Number 3, 2002
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Foreword
pp. 157-158(2)

Pharmacological implications in the switch from acute to chronic inflammation
pp. 159-171(13)
Authors: Dallegri F.; Ottonello L.

Effects of oxaprozin and of other 2-arylpropionic acid derivatives on nuclear factor kappaB(NF-kappaB) activation
pp. 173-183(11)
Author: Bevilacqua M.

Recent pharmacodynamic and pharmacokinetic findings on oxaprozin
pp. 185-239(55)
Authors: Rainsford K.D.; Omar H.; Ashraf A.; Hewson A.T.; Bunning R.A.D.; Rishiraj R.; Shepherd P.; Seabrook R.W.

A critical assessment of oxaprozin clinical profile in rheumatic diseases
pp. 241-284(44)
Authors: Kean W.F.; Kean R.; Buchanan W.W.

Alan Bennett, 8 March 1936-16 May 2002
pp. 285-288(4)
Author: Rainsford K.D.

Announcement
pp. 289-289(1)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A